The prevalence of central retinal vein occlusion was observed in middle age patients with post-covid syndrome multicenter study

Authors

  • Sanaa Ahmed
  • Ahmed Elmahdy
  • Eglal Kenawy
  • Marwa Abdulrehim
  • Samar Shoeir
  • Ghada Elmohaseb
  • Eman Youssef
  • Eman Bayoumy
  • Marwa Byomy

DOI:

https://doi.org/10.31989/bchd.v5i12.1016

Abstract

Background: The World Health Organization pronounced the Coronavirus disease (COVID-19) a pandemic on March 11, 2020. Patients with COVID-19 are more likely to have multisystem thromboembolic events, such as deep vein thrombosis and pulmonary emboli. This study estimates the clinical characteristics of patients with central retinal vein occlusion (CRVO) post-COVID-19 infection in three governorates of Egypt. 

Methods: A retrospective randomized study was conducted at Al-Azhar University Hospitals. We revised medical records for patients presented to Ophthalmology departments with CRVO. We considered all patients above 30 years old of both sexes without risk factors for central vein occlusion. 

Results:Central retinal vein occlusion was observed in post-COVID syndrome at younger ages, rather than the ordinary cases. The most presenting symptoms were fever, dyspnea, and a cough with significant hypoxia and elevated D-dimer level. 

Conclusion:Our study asserts the importance of more investigation into ocular complications associated with COVID-19. Physicians should be vigilant for acute visual symptoms in COVID-19 patients. Patients presenting with thromboembolism should be screened for COVID-19 infection as a presumed etiology. D-dimer may have an important prognostic value for disease severity. Anti-coagulant medications may be required on a long-term basis after COVID-19 infections.


Keywords: acute visual symptoms, ophthalmic evaluation, thromboembolism

Downloads

Published

2022-12-23

Issue

Vol. 5 No. 12 (2022): December 2022

Section

Research Articles

License

Copyright (c) 2022 FFC/Bioactive Compounds in Health and Disease

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors retain the copyright of their articles and grant the Functional Food Center (FFC) and its journals the right of first publication under the terms of the Creative Commons Attribution 4.0 International License.

This license permits unrestricted use, distribution, and reproduction in any medium, including commercial use, provided the original author(s) and source are properly credited. Authors may post and share their published work freely, provided that the original publication in this journal is acknowledged.

By submitting to this journal, authors confirm that their manuscripts are original, not under consideration elsewhere, and that they hold the necessary rights to grant this license. The Functional Food Center encourages open scientific exchange and allows derivative and extended works, provided attribution to the original publication is maintained.